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Anergic response to tuberculin (PPD) is well known in haemodialysis patients (HDp). This cross-sectional controlled 
study was conducted to analyse the correlation of PPD response with demographical features, nutritional 
parameters and the distribution of peripheral blood lymphocyte (PBL) subtypes. In this study 29 HDp (17 men; 12 
women; mean age 30.9 + 9.5 years) and 13 controls (eight men, five women; mean age 29.2 i- 6.4 years) were 
included. The mean time spent on dialysis was 20.5 & 17.4 months. The mean PPD response was lower in HDp than 
controls (7.5 i- 8 mm vs. 15 * 4 mm, P=O.OOl). Fourteen patients (48%) were PPD ( - ) (eight men, six women; mean 
age 34.1 % 11.1 years) and 15 were PPD (+) (normergic) (nine men, six women; mean age 26.8 + 3.4 years). No 
difference was observed between PPD ( - ) and (f ) groups for age, sex and time spent on dialysis. As nutritional 
parameters, body mass index, serum albumin, creatinine and cholesterol levels were measured and no differences 
were found between controls and the PPD ( - ) and (+) groups. Absolute lymphocyte counts were lower in HDP 
compared to controls (1290 l 296 vs. 1570 f 307 cells ml ~ i; P=O.Ol). PBL subtype percentages and absolute counts 
(CD3, CD4, CD8, CD4/CDS, HLADR+CD3+, CD16+56+, CD19) were also similar between PPD( - ) and (f) 
HDp. 
It was concluded that PPD response cannot be predicted by the distribution of PBL subtypes. The most probable 
cause of this observation is regulation of PPD reactivity by in situ immune cells whose composition is not reflected 
in the distribution of PBL. 
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Introduction 
A decreased response to tuberculin (PPD) has been 
described in haemodialysis patients. An increased rate of 
anergy and tuberculin nonreactivity in this group of 
patients has been recently reported by Smirnoff et al. (1). 
Previous studies have implicated malnutrition, a common 
disorder in this group of patients, as a factor in tuberculin 
reactivity (2-4). This cross-sectional controlled study was 
conducted to analyse the relationship between tuberculin 
response and patient demographic features, nutritional 
parameters, and the distribution of peripheral blood 
lymphocyte subgroups in haemodialysis patients. 
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Patients and Methods 
PATIENTS 
In this study, 29 haemodialysis patients (17 men, 12 women; 
mean age 30.9 + 9.5 years) and 13 age and sex-matched 
healthy controls (eight men, five women; mean age 
29.2 f 6.4 years) selected from medical staff were included. 
The Declaration of Helsinki’s recommendations for guiding 
physicians in biomedical research involving human subjects 
were followed (5). 
Exclusion criteria for this study were: history of tubercu- 
losis or diabetes mellitus; transfusion in the last year; HIV 
positive; or history of a recent viral infection. Demographic 
characteristics of the haemodialysis patients are shown in 
Table 1. All haemodialysis patients were dialysed using a 
Cuprophan rayon dialyser (Terumo, Tokyo, Japan) three 
times per week using bicarbonate dialysate. Blood samples 
were taken just before the dialysis sessions. Body mass 
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TABLE 1. Demographical and nutritional parameters of the study groups 
PPD(-)HDp PPD (+) HDp Control 
(n=14) (n= 15) (n= 13) Statistics 
Age (years) 32.1 z!z 10.1 30.6 * 9.6 29.2 It 6.4 n.s.* 
Sex (male/female) 8/6 916 8/5 n.s. 
Time spent on dialysis (months) 20.4 f 17.7 20.6 zt 17.1 n.s. 
BMI (kg m ~ “) 20.4 f 2.5 20.2 z!c 3.1 22.4 + 2.0 ns. 
Creatine (mg dl - ‘) 9.4 It 4.0 8.7 + 3.6 n.s. 
URR (%)T 58.5 * 5.4 61.2 f- 4.8 ns. 
Albumin (gr dl ~ ‘) 4.1 * 0.4 3.9 rt 0.4 4.0 zt 0.6 ns. 
Cholesterol (mg dl ~ ‘) 1X5.1 zt 41.7 165.4 & 30.1 180.2 i 36.7 ns. 
*n.s., Not significant; TURR, urea reduction ratio. 
index, serum albumin, creatinine and cholesterol levels were 
taken as measures of nutritional status. The urea reduction 
ratio (URR) calculated from pre- and postdialytic blood 
urea nitrogen levels was taken as the index of dialysis 
adequacy. 
TUBERCULIN TESTING 
Tuberculin reactivity in haemodialysis patients was assessed 
by response to intraderma15 IU PPD (Inter Vax Biologicals 
Limited, Canada) injected using the Mantoux technique 
into the volar surface of the forearm without the arterio- 
venous fistual. Induration was measured at 48 h. Induration 
of less than 5 mm was defined as PPD ( -). A second 
tuberculin test was performed in all PPD ( - ) patients for a 
booster effect 1 week later. 
PERIPHERAL BLOOD LYMPHOCYTE 
SUBTYPING 
Immunophenotypic analysis of the cells was performed 
using a FACScan flow cytometer (Becton Dickinson, 
U.S.A.) equipped with a 15 mW air-cooled argon-ion laser. 
The percentages of CD3, CD4, CD8, HLADR’CD3’, 
CD16 + 56+ and CD19 were measured using monoclonal 
antibodies in peripheral blood samples. A minimum of 1000 
events were counted on each sample. Data analysis was 
performed using Lysis II software (Becton Dickinson, 
U.S.A.). Gating was performed using 90” right angle 
scatter. The fluorescence signals were amplified on a 
logarithmic scale. 
STATISTICAL ANALYSIS 
All numerical values are reported as mean & SD. Statistical 
computations were done using SPSS for Windows V. 5.0 
(SPSS Inc. Illinois, U.S.A.). The numerical parameters 
deviated from normal distribution, therefore comparisons 
between groups [PPD (+) haemodialysis patients, PPD ( - ) 
haemodialysis patients, and controls] were done using the 
nonparametric Kruskal-Wallis ANOVA test. PcO.05 was 
taken as the level of significance. 
Results 
The mean PPD response was lower in haemodialysis 
patients than in controls (7.5 & 8 mm vs. 15 &4mm; 
P=O.OOl). Fourteen patients were tuberculin-negative 
(48%) (eight men, six women; mean age 34.1 * 11.1 years) 
and 15 (52%) were tuberculin responders (normergic) (nine 
men, six women, mean age 26.8 & 3.4 years). There was no 
statistically significant difference in age or sex of the tuber- 
culin responders and nonresponders. The mean time spent 
on dialysis was similar in responders and nonresponders; 
20.6 + 17.1 and 20.4 * 17.7 months, respectively (P>O.O5). 
Body mass indexes in PPD (+) haemodialysis patients, 
PPD ( - ) haemodialysis patients and healthy controls were 
20.2 + 3.1, 20.4 * 2.5, and 22.4 & 2.0 kg m- ’ respectively 
and did not reach statistical significance. Serum cholesterol 
and albumin levels were also similar across the group 
(Table 1). 
Absolute lymphocyte count was higher in normal con- 
trols than in the PPD (+) and ( -) haemodialysis groups; 
1570 f 307 vs. 1355 &250 and 1230 +Z 330 cells ml-’ 
respectively (P=O.O2). Comparison of peripheral blood 
lymphocyte subgroups (CD3, CD4, CD8, CD4/CD8, 
HLADR+CD3+, CD16+56’, CD19) between groups is 
shown in Table 2. The percentage of HLADR+CD3+ cells 
in haemodialysis patients was significantly higher compared 
to controls; 8.0 f 6.1% for PPD ( -) haemodialysis 
patients, 6.9 * 3.9% for PPD (+) haemodialysis patients 
and 2.2 & 1.8% for controls (P=O.Ol). The absolute count 
of HLADR+CD3+ cells was also increased in haemodialy- 
sis patients, but did not reach statistical significance. No 
difference in absolute count of PBL subtypes was observed 
between the PPD ( - ) and (+) groups (Table 2). 
Discussion 
Tuberculin anergy is common in haemodialysis patients 
(1,6). Malnutrition, a frequent problem in haemodialysis 
patients, has previously been implicated as a factor in 
tuberculin anergy (224). A recent study has shown that 
tuberculin anergy present at commencement of haemo- 
dialysis improves after prolonged dialysis (2) and explained 
TUBERCULIN AND PBL SUBTYPES IN HAEMODIALYSIS 121 
TABLE 2. Percentages of peripheral lymphocyte subsets in study groups 
PPD(-)HDp PPD (+) HDp Control 
(IZ’l4) (n= 15) (n= 13) Statistics 
Lymphocytes (cells ml - ‘) 1230 + 330 
CD3 % 72.1 + 6.2 
Absolute count 871 * 238 
CD4 % 39.9 It 12.1 
Absolute count 483 k 201 
CD8 % 30.6 zt 8.2 
Absolute count 356 + 91 
CD4/CD8 1.4 & 0.7 
HLADR+CD3+ % 8.0 ic 6.3 
Absolute count 98.6 i 85.0 
CD56’16’ % 14.6 zt 4.3 
Absolute count 185 zt 102 
CD19 % 10.0 * 4.3 
Absolute count 116+45 
1355 i 250 
70.6 * 8.0 
969zt211 
37.9 It 4.9 
518 zk 16 
33.2 zk 7.1 
459 i 144 
1.2hO.5 
6.9 k 3.9 
91.4 * 50.5 
16.8 zt 8.5 
219 * 105 
9.1 f 4.3 
128 & 69 
1570 * 307p P=O.O24 
65.1 + 5.4 n.s.* 
1020 * 266 n.s. 
39.0 & 5.3 n.s. 
557 zk 165 ns. 
26.6 dz 6.0 ns. 
497 zt 209 ns. 
1.2 zt 0.4 ns. 
2.2 dz 1.8t P=O.Ol 
69.6 * 40.4 n.s. 
18.2 & 6.6 n.s. 
249 * 150 ns. 
12.8 * 5.3 n.s. 
145 & 64 n.s. 
“n.s., Not significant; i-Healthy controls different from anergic and normergic haemodialysis 
patients. 
this observation by the improvement in appetite and less 
restricted diet with haemodialysis which improves nutrition 
(2). We were unable to show any relationship between 
tuberculin reactivity and duration of dialysis. This may be 
due to the longer time spent on dialysis in our patients (with 
only two patients on dialysis for less than 6 months). The 
lack of malnutrition in our patient group, as assessed by 
body mass index, serum albumin, creatinine and total 
cholesterol, may support the role of malnutrition in anergy. 
There have also been reports on the lack of a relationship 
between nutritional parameters and tuberculin anergy (6). 
In this study, we found that tuberculin reactivity was not 
affected by age or sex, which is consistent with the study by 
Smirnoff et al. (1). 
Another factor causing tuberculin anergy may be 
decreased cell-mediated immunity, as has been shown in the 
i7z vitro models of uremic rats (7). We found in our study 
that the total lymphocyte count was decreased in patients 
on haemodialysis compared to healthy controls, as has also 
been observed previously (8,9). On comparing PBL subtype 
percentages in haemodialysis patients and controls, the only 
significant difference was an increase in the subgroup of 
HLADR+CD3+ lymphocytes, markers of activated T cells, 
in haemodialysis patients (Table 2). This supports the 
previous observation by Ueki et al. (9). The increase in the 
percentage of activated T cells was thought to be related to 
nonspecific stimulation of T cells by the dialysis membrane 
or other chronic antigenic stimulations. However, activated 
T-lymphocyte subgroup percentages were similar in PPD 
( - ) and (f) patients in our study. 
In conclusion, we believe that the tuberculin response in 
haemodialysis patients cannot be predicted by quantitative 
analysis of peripheral blood lymphocyte subtypes. The 
differences in tuberculin reactivity may originate from 
qualitative differences in lymphocyte subsets or differences 
in the dermal in situ immune response. 
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